New drug OPT101 takes first step: safety check in healthy volunteers
Knowledge-focused
Completed
This early-stage study tested the safety of a new drug called OPT101 in 14 healthy adults. Participants received either the drug or a placebo, and researchers monitored for side effects, vital signs, and lab changes. The goal was to find safe doses and understand how the body pro…
Phase: PHASE1 • Sponsor: Op-T LLC • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:01 UTC